1[1]Cavarocchi NC,Pluth TR,Schaff HV,et al.Complement cativation during acrdiopulmonary bypass comparision of bubble and membrane oxygenator.J Thorac Cardiovasc Surg,1986,91 (2):252-258
2[2]Gillinov AM,Redomond TM,Zehr KT,et al.Inhibition of neutrophil adhesion during cardiopulmonary bypass.Ann Thorac Surg,1994,57 (1):126-133
3[3]Andersen LW,Landow L,Baek L,et al.Association between gastric intram-ucosal PH and splanchnic endoxin,antibody to endotoxin,and yumor necrosis factor-alpha concertration in patients undergoing cardiopulmonary bypass.Crit Care Med,1993,21 (2):210-217
4[4]Dauber IM,Parsons PE,Aek L,et al.Peipherial bypass-induced pulmonary and coronary vascular injury.Assosiattion with increased levels of tumor necrosis factor cardiopulmonary bypass.Circulation,1993,88 (2):726-735
5[5]Bultler J,Paker D,Pillai R,et al.Effect of cardiopulmonary bypass on systemic release of neutrophil elastase tumor neucrosis factor.J Thorac Cardiovasc Surg,1993,105 (1):25-30
6[6]Nagamine S,Tabayashi K,Haneda K,et al.A clinical study of resperstory complication after cardiopulmonary bypass,with specical reference to complement activiation,WBC,and granulocyte elastase.Nippon Geka Gakkai Zasslhi,1994,95 (5):348-353
7[7]Royston D,Fleming JS,Dosia JB,et al.Increased production of peroxidation products associated with cardiovac operations.Evidence for free radial generation.J Thorac Cardiovasc,1986,91 (5):759-766
8[8]Misoph M,J Babin K,Schwender S,et al.Response of the cellular immune system to cardiopulmonary bypass in vivo.Thorac Cardiovasc Surg,1997,45(5):217-223
9[9]Wang X,Andersson R.The role of endothelial cell in the systemic inflammatory response syndrome and multiple system organ failure.Eur J Surg,1995,161 (10):703-713
10[10]Ansley DM,Qayumi A,Duncan S,et al.Platelet activating factor and thromboxane B2 production after cardiopulmonary bypass.J Invest Surg,1997,10(3):87-95
